Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression
靶向CD39联合IL-2/抗IL-2复合物可增强细胞毒性免疫并限制肿瘤进展。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1730342
Abrate, Carolina; Brunotto, Valentina; Bossio, Sabrina N; Boccardo, Santiago; Tosello Boari, Jimena; Caudana, Pamela; Hernandez, Lara; Gimenez, Camila; Theumer, Martin G; Sedlik, Christine; Amezcua-Vesely, Maria C; Robson, Simon C; Gruppi, Adriana; Piaggio, Eliane; Acosta Rodríguez, Eva V; Montes, Carolina L
肿瘤
肿瘤免疫
CD39
CD3
IL-2
细胞生物学
毒理研究
免疫/内分泌